These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 38258129)

  • 1. Potentially Harmful Excipients: State of the Art for Oral Liquid Forms Used in Neonatology and Pediatrics Units.
    Bobillot M; Delannoy V; Trouillard A; Kinowski JM; Sanchez-Ballester NM; Soulairol I
    Pharmaceutics; 2024 Jan; 16(1):. PubMed ID: 38258129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The STEP (Safety and Toxicity of Excipients for Paediatrics) database: part 2 - the pilot version.
    Salunke S; Brandys B; Giacoia G; Tuleu C
    Int J Pharm; 2013 Nov; 457(1):310-22. PubMed ID: 24070789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harmful excipients in medicines for neonates in Spain.
    Garcia-Palop B; Movilla Polanco E; Cañete Ramirez C; Cabañas Poy MJ
    Int J Clin Pharm; 2016 Apr; 38(2):238-42. PubMed ID: 26960405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of ethanol and other potentially harmful excipients in pediatric oral medicines: survey of community pharmacies in a Nigerian City.
    Soremekun R; Ogbuefi I; Aderemi-Williams R
    BMC Res Notes; 2019 Jul; 12(1):460. PubMed ID: 31349864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excipients in Neonatal Medicinal Products: Never Prescribed, Commonly Administered.
    Valeur KS; Holst H; Allegaert K
    Pharmaceut Med; 2018; 32(4):251-258. PubMed ID: 30174435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neonatal Formulations: The Need for a Tailored, Knowledge Driven Approach.
    Allegaert K; Cosaert K; van den Anker JN
    Curr Pharm Des; 2015; 21(39):5674-9. PubMed ID: 26323412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excipients in the Paediatric Population: A Review.
    Rouaz K; Chiclana-Rodríguez B; Nardi-Ricart A; Suñé-Pou M; Mercadé-Frutos D; Suñé-Negre JM; Pérez-Lozano P; García-Montoya E
    Pharmaceutics; 2021 Mar; 13(3):. PubMed ID: 33805830
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Meyers RS; Thackray J; Matson KL; McPherson C; Lubsch L; Hellinga RC; Hoff DS
    J Pediatr Pharmacol Ther; 2020; 25(3):175-191. PubMed ID: 32265601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Current States, Challenges, Ongoing Efforts, and Future Perspectives of Pharmaceutical Excipients in Pediatric Patients in Each Country and Region.
    Saito J; Agrawal A; Patravale V; Pandya A; Orubu S; Zhao M; Andrews GP; Petit-Turcotte C; Landry H; Croker A; Nakamura H; Yamatani A; Salunke S
    Children (Basel); 2022 Mar; 9(4):. PubMed ID: 35455497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hospitalised neonates in Estonia commonly receive potentially harmful excipients.
    Lass J; Naelapää K; Shah U; Käär R; Varendi H; Turner MA; Lutsar I
    BMC Pediatr; 2012 Aug; 12():136. PubMed ID: 22931304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentially harmful excipients in neonatal medicines: a pan-European observational study.
    Nellis G; Metsvaht T; Varendi H; Toompere K; Lass J; Mesek I; Nunn AJ; Turner MA; Lutsar I;
    Arch Dis Child; 2015 Jul; 100(7):694-9. PubMed ID: 25854872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug Formulations: Standards and Novel Strategies for Drug Administration in Pediatrics.
    Thabet Y; Klingmann V; Breitkreutz J
    J Clin Pharmacol; 2018 Oct; 58 Suppl 10():S26-S35. PubMed ID: 30248193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potentially harmful excipients in prescribed medications in a Neonatal Intensive Care Unit in Kosovo and available safer alternatives.
    Koshi B; Grapci AD; Nebija D; Selmani PB; Morina R; Crcarevska MS; Dodov MG; Raichki RS
    Turk J Pediatr; 2022; 64(1):49-58. PubMed ID: 35286030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceutical Excipient Exposure in a Neonatal Intensive Care Unit.
    Nasrollahi S; Meera NK; Boregowda S
    Indian Pediatr; 2020 Sep; 57(9):801-804. PubMed ID: 32999107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Cumulative Daily Tolerance Levels of Potentially Toxic Excipients Ethanol and Propylene Glycol Are Commonly Exceeded in Neonates and Infants.
    Valeur KS; Hertel SA; Lundstrøm KE; Holst H
    Basic Clin Pharmacol Toxicol; 2018 May; 122(5):523-530. PubMed ID: 29281181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence and pattern of pharmaceutical and excipient exposure in a neonatal unit in Slovenia.
    Fister P; Urh S; Karner A; Krzan M; Paro-Panjan D
    J Matern Fetal Neonatal Med; 2015; 28(17):2053-61. PubMed ID: 25316561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceutical excipients. Adverse effects associated with inactive ingredients in drug products (Part I).
    Golightly LK; Smolinske SS; Bennett ML; Sutherland EW; Rumack BH
    Med Toxicol Adverse Drug Exp; 1988; 3(2):128-65. PubMed ID: 3287089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and Biopharmaceutical Challenges of Excipients in Off-Label Pediatric Formulations.
    Belayneh A; Tadese E; Molla F
    Int J Gen Med; 2020; 13():1051-1066. PubMed ID: 33204140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-Appropriate Formulations Including Pharmaceutical Excipients in Neonatal Medicines.
    Kogermann K; Lass J; Nellis G; Metsvaht T; Lutsar I
    Curr Pharm Des; 2017; 23(38):5779-5789. PubMed ID: 28950820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.